ZYBERNO
Stock Report
Updated Sep 2, 2026

VYCOR MEDICAL, INC. (VYCO)

Healthcare • OTC

$0.07

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
8.0/100
POOR BUSINESS
VYCOR MEDICAL, INC. (VYCO) scores 8/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):POOR (4.8%)
Return on Capital (Capital Efficiency):POOR (9.9%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

VYCOR MEDICAL, INC. (VYCO) stock report — Zyberno Score 8/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, VYCO generated -$122.17K in Owner Earnings.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.07
Market Cap:$2.24M

Valuation Multiples (2)

P/S Ratio:1.24x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$2.13M
Ev Ebitda Ratio:14.67x

Price Action & Momentum (3)

Momentum Percentile:8 / 100
% of 52-Week High:33.5%
B. Profitability Assessment

Margin Analysis (3)

Operating Margin Ttm:4.8%
Net Margin Ttm:-3.3%
Ebitda Margin:8.0%

TTM Performance (3)

Gross Margin Ttm:83.4%
Operating Margin Ttm:4.8%
Net Margin Ttm:-3.3%

Yield Metrics (2)

Earnings Yield:$0.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-100.0%
Latest Earnings Filed:2026-08-14

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):12.1%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):-13.4%

Cash Flow Growth (Linear) (1)

Operating Cash Flow Growth Rate (Linear):92.7%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):-41.5%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.13x
Quick Ratio:0.09x
Cash Ratio:0.03x

Leverage Analysis (1)

Debt To Ebitda:0.37x

Coverage Ratios (2)

Interest Coverage Ratio:2.45x
Times Interest Earned:2.45

Capital Structure (4)

Working Capital:-4,294,543.00
Cash And Cash Equivalents:158,907.00
Long Term Debt:$26.70K
Net Debt:-$105.51K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.81M
Linear Growth: 12.1%
📊 Click to view full VYCO Revenue analysis & methodology →
Cost Of Revenue Ttm:$300.57K

Profitability Breakdown (2)

Gross profit TTM: $1.51M
Linear Growth: 9.5%
📊 Click to view full VYCO Gross Profit analysis & methodology →
Operating income TTM: $86.56K
Linear Growth: -41.5%
📊 Click to view full VYCO Operating Income analysis & methodology →

Bottom Line Performance (3)

Net income TTM: -$59.93K
Linear Growth: -13.4%
📊 Click to view full VYCO Net Income analysis & methodology →
Income Before Tax:-$56.40K
Ebitda Ttm:145,182.00

Operating Expenses (5)

Operating Expenses:1,458,681.00
R And D Expense:15,725.00
Sga Expense:1,400,058.00
Income Tax Expense:$0.00
Interest Expense:13,864.80

Expense Ratios (3)

R And D To Revenue Percentage:3.8%
Sga To Revenue Percentage:334.7%
Ebitda Margin:8.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$813.17K
Current Assets:$635.88K
Ppe Net:101,373.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:5,064,398.00
Current Liabilities:4,930,420.00
Long Term Debt:$26.70K
Short Term Debt:$26.70K

Equity & Capital (3)

Equity:-$4.25M
Retained Earnings:-$33.81M
Common Stock:55,000,000.00

Working Capital Items (3)

Accounts Receivable:202,447.00
Inventory:190,508.00
Accounts Payable:111,784.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $112.86K
Linear Growth: 92.7%
-$128.25K

Investment Activities (1)

Investing Cash Flow:$2.14K

Financing Activities (3)

Financing Cash Flow:-$14.91K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:58,623.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):0.00
$0.00
Earnings Per Share Ttm:-$0.00

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.05
Operating Cash Flow Per Share:-$0.00

Book Value & Capital (2)

Book Value Per Share:-$0.13
Cash Per Share:0.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:2.10x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:8.93x
Days Sales Outstanding Ttm:40.88

Inventory Management (2)

Inventory Turnover Ttm:1.58x
Days Inventory Outstanding Ttm:231.34

Payables & Cash Cycle (2)

Days Payable Outstanding:135.74
Cash Conversion Cycle:136.48
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$122.17K
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (3)

Revenue Growth Rate (Linear):12.1%
Net Income Growth Rate (Linear):-13.4%
Operating Income Growth Rate (Linear):-41.5%

Cash Flow Growth Rates (1)

Operating Cash Flow Growth Rate (Linear):92.7%

Other Growth Rates (1)

Gross Profit Growth Rate (Linear):9.5%
C. Company Profile & Context

Corporate Information (6)

Symbol:VYCO
Company Name:VYCOR MEDICAL, INC.
Sector:Healthcare
Industry:Medical Devices
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:33.37M
Shares Outstanding Basic:33.37M
Shares Outstanding Diluted:33.37M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-02 00:13:58 UTC
Data Timestamp:2026-08-23T00:33:50.394926
Scroll to Top